Skip to main content
. 2021 Jan 20;28(e1):e2–e7. doi: 10.1136/ejhpharm-2020-002652

Table 2.

Study eligibility criteria specified according to PICOS

Inclusion criteria Exclusion criteria
Participants Patients on medication Individuals with no health condition
Interventions Non-medical switching Generic substitution; biosimilar substitution; dosage change
Comparisons None None
Outcomes Economic No economic outcomes
Study design  Economic evaluation Reviews; meta-analysis; non-economic evaluations